JACKSON, Miss.- The drug company Cephalon has been accused of intentionally defrauding the Federal Patent and Trademark Office.
The aim was to secure a patent for Provigil at the same time as other generic versions were scheduled to hit the market. Those generic versions would have proved cheaper as well.
The drug Provigil is prescribed to individuals who suffer from sleep disorders.
Attorney General Jim Hood says those who bought the drug Provigil could be eligible for restitution after a $125 million settlement. For Mississippi, the state would get about $1.27 million with $451,757 going to those who bought the drug.
Cephalon’s efforts delayed the availability of the less expensive generic versions of the drug.
